Kintor Pharmaceutical Limited (9939.HK)

HKD 1.1

(-0.9%)

Net Debt Summary of Kintor Pharmaceutical Limited

  • Kintor Pharmaceutical Limited's latest annual net debt in 2023 was -191.57 Million CNY , down -167.1% from previous year.
  • Kintor Pharmaceutical Limited's latest quarterly net debt in 2023 FY was -191.57 Million CNY , down -167.1% from previous quarter.
  • Kintor Pharmaceutical Limited reported annual net debt of 285.52 Million CNY in 2022, up 79.8% from previous year.
  • Kintor Pharmaceutical Limited reported annual net debt of 158.8 Million CNY in 2021, down -28.03% from previous year.
  • Kintor Pharmaceutical Limited reported quarterly net debt of 321.87 Million CNY for 2023 Q2, up 12.73% from previous quarter.
  • Kintor Pharmaceutical Limited reported quarterly net debt of -191.57 Million CNY for 2023 Q4, down -159.52% from previous quarter.

Annual Net Debt Chart of Kintor Pharmaceutical Limited (2023 - 2014)

Historical Annual Net Debt of Kintor Pharmaceutical Limited (2023 - 2014)

Year Net Debt Net Debt Growth
2023 -191.57 Million CNY -167.1%
2022 285.52 Million CNY 79.8%
2021 158.8 Million CNY -28.03%
2020 220.63 Million CNY 245.28%
2019 63.9 Million CNY -8.06%
2018 69.5 Million CNY 118.52%
2017 31.8 Million CNY 429.95%
2016 -9.63 Million CNY 62.48%
2015 -25.69 Million CNY -1173.55%
2014 -2.01 Million CNY 0.0%

Peer Net Debt Comparison of Kintor Pharmaceutical Limited

Name Net Debt Net Debt Difference
Uni-Bio Science Group Limited -76.36 Million HKD -150.86%
CK Life Sciences Int'l., (Holdings) Inc. 5.26 Billion HKD 103.637%